Rimon
Rimon
Longevity MYSTERY: Why the ITP Study FAILED? (ep.2)
Longevity MYSTERY: Why the ITP Study FAILED? (ep.2)
Longevity MYSTERY: Why the ITP Study FAILED? (ep.2)
Saturday 8th July 2023
Rimon unpacks the ITP study on Fisetin and Quercetin, exploring its findings and what they mean for longevity and health.
50 minutes
Informative
Empowering
Educational
Thought-provoking
Insightful
About this podcast
Author:
Rimon
Overview:
Categories:
Holistic Health Innovations
Mindful Recovery
Mindfulness & Technology in Health
Innovative Treatments & Recovery Paths
Financial Health in Recovery
Links:
Visit site
Episodes:
87 (View all)
Do you want to link to this podcast?
Get the buttons here!Longevity Secrets: The Truth Behind the ITP Study on Fisetin and Quercetin
Episode Overview
- Delving into the strengths and weaknesses of the ITP in conducting longevity experiments
- Examining the potential impact of low-dose fisetin on senescent cells and maximum lifespan in mice
- Comparing the dose of fisetin used in the ITP study with human studies
- Providing a personal perspective on fisetin and quercetin and their potential impact on human health and longevity
If you take out the obvious smoking-related death of COPD, 82 percent of death is attributable to cardiovascular disease, cancer, Alzheimer's disease, and complications of diabetes. As Dr. Peter Ortiz said, the four major causes of death in humans are cardiovascular disease, diabetes, Alzheimer's disease, and cancer.
Imagine diving into the world of longevity research and finding out that some of the most popular supplements might not be as effective as you thought. In this episode of 'The Wellness Messiah Podcast', Rimon takes you on a journey through the intricate details of the ITP study that left many in the longevity community scratching their heads. Dr.
Brad Stanfield's surprising decision to stop taking Fisetin and Quercetin sparked a lot of questions, especially when it contradicted other experts like Dr. David Sinclair and Dr. Robbins. So, what’s really going on here? Rimon breaks down the ITP study, an investigation that aimed to test the lifespan benefits and senescent cell removal capabilities of Fisetin. He digs into the strengths and flaws of the ITP’s methods, including their use of diverse mice and replication of experiments across multiple sites.
But it’s not all smooth sailing; Rimon also highlights potential biases and limitations, particularly in how pharmaceutical drugs are tested. One of the most intriguing parts? The dose of Fisetin used in the study. Was it too low to show any real benefits? Rimon doesn't just stop at the data; he offers his own perspective on whether Fisetin and Quercetin should have a place in your health regimen.
Whether you're a supplement enthusiast or just curious about the science behind longevity, this episode is packed with insights that could change how you think about these popular supplements.